KCT0000445招募中未知
Safety and efficacy of allogeneic umbilical cord blood therapy for children with global developmental delay
Bundang CHA General Hospital0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 6(Month) 至 15(Year)（—）
- 性别
- All
入选标准
- •1. Global developmental delay
- •2. Written consent of a legal representative
- •3. Willing to comply with all study procedure and participate in the study for 12 months
- •4. Eligible depending on the principle investigator
排除标准
- •1. Aspiration pneumonia, impaired renal function, uncontrolled epilepsy at enrollment
- •2. Poor cooperation with study procedure
- •3. Persistent epilepsy despite of three kinds of antiepileptic drugs
- •4. Not eligible according to the priciple investigator
研究者
相似试验
招募中
不适用
Allogeneic UCB Therapy With EPO in Children With CPDiseases of the nervous systemKCT0000950Bundang CHA General Hospital120
已完成
不适用
Allogeneic UCB Therapy With EPO in Children With CPCerebral PalsyNCT01991145MinYoung Kim, MD, PhD92
已完成
1 期
Allogeneic Umbilical Cord Blood Therapy for StrokeStrokeNCT01884155MinYoung Kim, M.D.5
已完成
2 期
Effects of umbilical cord derived stem cells injection in the treatment of children with cerebral palsyIRCT201706176907N13Tehran University of Medical Sciences108
已完成
1 期
Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral PalsyCerebral PalsyNCT02599207Joanne Kurtzberg, MD15